Secondly, the validation of ZBTB16 expression in lung cancer was conducted solely through quantitative Polymerase Chain Reaction (qPCR), omitting other techniques such as Western blotting (WB) or Immunohistochemistry (IHC) for a more comprehensive validation. The gene discussed is ZBTB16; the disease is lung cancer.